Atlas Trials

4D Molecular Therapeutics

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch 4D Molecular Therapeutics

RecordFirmDate
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration (NCT07064759)4D Molecular Therapeutics2025-07-22
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration (NCT06864988)4D Molecular Therapeutics2025-03-03
4D-150 in Patients With Diabetic Macular Edema (NCT05930561)4D Molecular Therapeutics2023-08-09
4D-310 in Adults With Fabry Disease and Cardiac Involvement (NCT05629559)4D Molecular Therapeutics2022-10-16
4D-710 in Adult Patients With Cystic Fibrosis (NCT05248230)4D Molecular Therapeutics2022-03-29
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration (NCT05197270)4D Molecular Therapeutics2021-12-09
An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease (NCT04519749)4D Molecular Therapeutics2020-09-01
4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP) (NCT04517149)4D Molecular Therapeutics2020-06-09
Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia (NCT04483440)4D Molecular Therapeutics2020-06-02

Track 4D Molecular Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.